$1.97B | |
$30.00 | |
$42.86 | |
$1.77 | |
$29.95 | |
$-0.13 | |
-0.43% | |
23K |
Pharvaris N.V. (PHVS) is currently trading at $29.52 as of 2026-05-12 14:47:00, reflecting a -0.43% move ($-0.13) from the previous close.
In the short term, the stock has returned +5.89% over the past four weeks. Over the last 12 months, Pharvaris N.V. has recorded a +75.62% price change, indicating a Strong performance relative to the broader market.
Over the past seven days, Pharvaris N.V. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $29.90 to the latest recorded price of $29.52, reflecting an intraday change of -0.43%. Daily movements highlight shifts in trading volume (22,654), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, PHVS has delivered a +5.89% return over the past month and a +75.62% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.
You can buy and trade PHVS on MEXC in three simple steps:
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
| Industry | -- |
| Employees | 129 |
| Sector | -- |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 PHVS = 29.521 USD